Review: taking Cipro and Pepcid together


Summary

Drug interactions are reported among people who take Cipro and Pepcid together. This review analyzes the effectiveness and drug interactions between Cipro and Pepcid. It is created by eHealthMe based on reports of 640 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Cipro

Cipro has active ingredients of ciprofloxacin. It is often used in urinary tract infection. (latest outcomes from Cipro 5,914 users)

Pepcid

Pepcid has active ingredients of famotidine. It is often used in gastrooesophageal reflux disease. (latest outcomes from Pepcid 27,965 users)

On Sep, 17, 2016

640 people who take Cipro, Pepcid are studied.


Number of reports submitted per year:

Cipro and Pepcid drug interactions.

Drug effectiveness over time:

Cipro:
  • < 1 month: 66.0% - (2 of 3 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 1 people)
Pepcid:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Cipro:
  • female: 33.0% - (1 of 3 people)
  • male: 100.0% - (1 of 1 people)
Pepcid:
  • female: 66.0% - (2 of 3 people)
  • male: 66.0% - (2 of 3 people)

Drug effectiveness by age:

Cipro:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Pepcid:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 66.0% - (2 of 3 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • oedema peripheral
  • diabetic foot
  • epistaxis
  • hyperkalaemia
  • injury
  • depression
  • musculoskeletal discomfort
  • musculoskeletal pain
  • pain in extremity
  • renal failure
1 - 6 months:
  • angina pectoris
  • c-reactive protein increased
  • device related infection
  • enterocutaneous fistula
  • haemoptysis
  • herpes zoster
  • localised intraabdominal fluid collection
  • lung infection
  • pneumonia
  • pneumonia fungal
6 - 12 months:
  • acute graft versus host disease in skin
  • acute myeloid leukaemia recurrent
  • cellulitis
  • crying
  • depression
  • drug ineffective
  • feeling jittery
  • insomnia
  • multi-organ failure
  • nasal septum perforation
1 - 2 years:
  • acute graft versus host disease in intestine
  • acute graft versus host disease in liver
  • acute graft versus host disease in skin
  • altered state of consciousness
  • anaphylactoid reaction
  • blood lactate dehydrogenase increased
  • cardiac tamponade
  • constipation
  • convulsion
  • cytomegalovirus infection
2 - 5 years:
  • androgen deficiency
  • angina pectoris
  • arthritis
  • bone disorder
  • cerebrovascular accident
  • chronic obstructive pulmonary disease
  • death
  • fall
  • femur fracture
  • gastrointestinal disorder
5 - 10 years:
  • arthritis
  • bipolar disorder
  • bone disorder
  • chronic obstructive pulmonary disease
  • foot fracture
  • gait disturbance
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • pain in extremity
10+ years:
  • anxiety
  • emotional distress
  • back pain
  • cardiac disorder
  • cerebral haemorrhage
  • compression fracture
  • deep vein thrombosis
  • depression
  • foot fracture
  • gallbladder disorder
not specified:
  • nausea
  • pain
  • pyrexia
  • anxiety
  • dyspnoea
  • injury
  • chest pain
  • back pain
  • osteonecrosis of jaw
  • urinary tract infection

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • anxiety
  • pyrexia
  • dyspnoea
  • injury
  • urinary tract infection
  • osteonecrosis of jaw
  • pain in extremity
  • back pain
male:
  • hypotension
  • fatigue
  • pain
  • depression
  • pyrexia
  • chest pain
  • abdominal pain
  • constipation
  • nausea
  • dyspnoea

Most common drug interactions by age *:

0-1:
  • abdominal compartment syndrome
  • ascites
  • atrial septal defect
  • blood lactic acid increased
  • cholecystitis
  • cholelithiasis
  • coagulopathy
  • duodenal perforation
  • electroencephalogram abnormal
  • enterococcal infection
2-9:
  • grand mal convulsion
  • anaphylactic reaction
  • brain neoplasm malignant
  • convulsion
  • drooling
  • dystonia
  • malignant neoplasm progression
  • masked facies
  • pyelonephritis
  • tic
10-19:
  • abdominal pain
  • biliary dyskinesia
  • depression
  • nausea
  • appendicitis
  • back pain
  • cholecystitis chronic
  • emotional distress
  • fear of death
  • gastrointestinal disorder
20-29:
  • anxiety
  • deep vein thrombosis
  • injury
  • pulmonary embolism
  • cellulitis
  • pain in extremity
  • muscle spasms
  • depression
  • oedema peripheral
  • ovarian cyst
30-39:
  • pulmonary embolism
  • chest pain
  • weight increased
  • type 2 diabetes mellitus
  • neuropathy peripheral
  • injury
  • abdominal pain
  • cardiac failure congestive
  • depression
  • headache
40-49:
  • pyrexia
  • anxiety
  • nausea
  • pain
  • injury
  • neck pain
  • back pain
  • dyspnoea
  • compression fracture
  • osteonecrosis of jaw
50-59:
  • pain in jaw
  • urinary tract infection
  • musculoskeletal pain
  • hypoaesthesia
  • osteonecrosis of jaw
  • pain in extremity
  • spinal osteoarthritis
  • acquired oesophageal web
  • arthralgia
  • intervertebral disc protrusion
60+:
  • nausea
  • hypotension
  • pain
  • dyspnoea
  • fatigue
  • asthenia
  • pyrexia
  • hypertension
  • anxiety
  • urinary tract infection

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Cipro and Pepcid?

Can you answer these questions?

More questions for: Cipro, Pepcid

You may be interested in these reviews

More reviews for: Cipro, Pepcid

On eHealthMe, Cipro (ciprofloxacin) is often used to treat urinary tract infection. Pepcid (famotidine) is often used to treat gastrooesophageal reflux disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.